Lustovacka_5-2025

Gastroenterologie a hepatologie Gastroenterology and Hepatology

EUS-FNA diagnosis

Benign

Adenocarcinoma

NET

Unspecified primary malignancy

Other*

Non-diagnostic

%

8.3%

61.6%

7.6%

10%

3.1%

9.4%

surgery

15.4%

15.3%

25%

26.7%

60%

33.3%

chemotherapy

N/A

48%

8.3%

43.8%

20%

13.3%

surgery and chemotherapy

N/A

10.2%

0%

13.3%

0%

0%

3-year survival

69.3%

10.2%

66.7%

25%

80%

66.7%

* 2× metastasis, 1× lymphoma, 1× autoimmune pancreatitis, 1× solid pseudopapillary tumor Koller T, Vrbová P, Holst G et al. Clinical utility of EUS-guided sampling of solid pancreatic lesions: diagnostic spectrum, treatment strategies, and prognostic insights from a single center. Gastroent Hepatol 2025; 79(5): 344–355. doi: 10.48095/ccgh2025344.

,asopis ,eské gastroenterologické spole«nosti, ,eské hepatologické spole«nosti, Slovenskej gastroenterologickej spolo«nosti a Slovenskej hepatologickej spolo«nosti Vydává ,LS JEP – indexed in SCOPUS, CHEMICAL TITLES, EXCERPTA MEDICA/EMBASE, CHEMICAL ABSTRACTS, EBSCO, INIS Atomindex, Food Science and Technology Abstracts, Bibliographia Medica ,echoslovaca, Index Copernicus, Bibliovigilance

GASTROINTESTINÁLNÍ ONKOLOGIE

80 let

Hodnocení programu screeningu kolorektálního karcinomu v ,R Endoskopická lé«ba poopera«ní stenózy jícnu Clinical utility of EUS-guided sampling of solid pancreatic lesions Skríning kolorektálneho karcinómu na Slovensku Stereotaktická radioterapie v lé«b³ hepatocelulárního karcinomu 8. kongres ,eské gastroenterologické spole«nosti ,LS JEP: abstrakta pâednášek ISSN ͷ;Ͷͺ-ͽ;ͽͺ (Print); ISSN ͷ;Ͷͺ-;Ͷ͹X (On-line)

âíjen ͸Ͷ͸ͻ ro«ník ͽͿ «íslo ͻ